Differential effect of hesperidin on Th1, Th2, Th17, and proinflammatory cytokines production from splenocyte of Schistosoma mansoni-infected mice

Central-European Journal of Immunology

Volumn 38, Issue 1, 2013, Pages 29-36

  Allam, Gamal ^a,b   Abuelsaad, Abdelaziz S A ^a,b  

^a TAIF UNIVERSITY   (Saudi Arabia)

^b Beni Suef University   (Egypt)

Author keywords

Hesperidin; Proinflammatory cytokines production; Schistosomiasis; Th1; Th17; Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HESPERIDIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GRANULOMATOUS INFLAMMATION; IMMUNOPATHOLOGY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SPLEEN CELL; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 84881319426     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2013.34355     Document Type: Article

References (83)

1. Pearce EJ, MacDonald AS (2002): The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499-511.
2. Warren KS, Domingo EO, Cowan RBT (1967): Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol 51: 735-756.
3. Hernandez HJ, Wang Y, Tzellas N, et al. (1997): Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. Eur J Immunol 27: 1170-1176.
4. Yu L, Sun X, Yang F, et al. (2012): Inflammatory cytokines IFN-γ, IL-4, IL-13 and TNF-α alterations in schistosomiasis: a meta-analysis. Parasitol Res 110: 1547-1552.
5. O'Garra A(1998): Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8: 275-283.
6. Seder RA, Paul WE (1994): Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 12: 635-763.
7. Szabo SJ, Dighe AS, Gubler U, et al. (1997): Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 185: 817-824.
8. Mountford AP, Coulson PS, Sher AW, Cheever A, et al. (1999): Interleukin-12 can directly induce T-helper 1 responses in interferon-gamma (IFN-gamma) receptor-deficient mice, but requires IFN-gamma signalling to downregulate T-helper 2 responses. Immunol 97: 588-594.
9. Grzych JM, Pearce EJ, Cheever A, et al. (1991): Egg deposition is the major stimulus for the production of Th2 cytokines in murine Schistosomiasis mansoni. J Immunol 146: 1322-1327.
10. Wynn TA, Cheever AW, Williams ME, et al. (1998): IL-10 regulates liver pathology in acute murine schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol 160: 4473-4480.
11. Kaplan MH, Whitfield JR, Boros DL, et al. (1998): Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol 160: 1850-1856.
12. Jankovic D, Kullberg MC, Noben-Trauth N, et al. (1999): Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J Immunol 163: 337-342.
13. Fallon PG, Richardson EJ, McKenzie GJ, et al. (2000): Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 164: 2585-2591.
14. Fallon PG, Dunne DW(1999): Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection. J Immunol 162: 4122-4132.
15. Zhou S, Liu S, Song G, et al. (2000): Protective immunity induced by the full-length cDNAencoding paramyosin of Chinese Schistosoma japonicum. Vaccine 18: 3196-3204.
16. Fonseca CT, Brito CF, Alves JB, et al. (2004): IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway. Vaccine 22: 503-510.
17. Wynn TA, Jankovic D, Hieny S, et al. (1995): IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J Immunol 154: 4701-4709.
18. Wynn TA, Reynolds A, James SL, et al. (1996): IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol 157: 4068-4078.
19. Mountford AP, Pearlman E (1998): Interleukin-12 and the host response to parasitic helminths; the paradoxical effect on protective immunity and immunopathology. Parasit Immunol 20: 509-517.
20. Anderson S, Shires VL, Wilson RA, et al. (1998): In the absence of IL-12, the induction of Th1-mediated protective immunity by the attenuated schistosome vaccine is impaired, revealing an alternative pathway with Th2-type characteristics. Eur J Immunol 28: 2827-2838.
21. Anderson S, Shires VL, Wilson RA, et al. (1999): Formation of multinucleated giant cells in the mouse lung is promoted in the absence of interleukin-12. Am J Respir Cell Mol Biol 20: 371-378.
22. El Ridi R, Tallima H, Salah M, et al. (2009): Transforming growth factor-beta and Th17 responses in resistance to primary murine schistosomiasis mansoni. Cytokine 48: 239-245.
23. Park H, Li Z, Yang XO, et al. (2005): A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141.
24. Harrington LE, Hatton RD, Mangan PR, et al. (2005): Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
25. Nakae S, Nambu A, Sudo K, et al. (2003): Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171: 6173-6177.
26. Langrish CL, Chen Y, Blumenschein WM, et al. (2005): IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240.
27. Chen Y, Langrish CL, McKenzie B, et al. (2006): Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116: 1317-1326.
28. Yen D, Cheung J, Scheerens H, et al. (2006): IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116: 1310-1316.
29. Rutitzky LI, da Rosa LJ, Stadecker MJ (2005): Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 175: 3920-3926.
30. Rutitzky LI, Bazzone L, Shainheit MG, et al. (2008): IL-23 is required for the development of severe egg induced immunopathology in schistosomiasis and for lesional expression of IL-17. J Immunol 180: 2486-2495.
31. Shainheit MG, Smith PM, Bazzone LE, et al. (2008): Dendritic cell IL-23 and IL-1 production in response to schistosome eggs induces Th17 cells in a mouse strain prone to severe immunopathology. J Immunol 181: 8559-8567.
32. Pearce EJ, Kane M, Sun CJ, et al. (2004): Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev 201: 117-126.
33. Hesse M, Piccirillo CA, Belkaid Y, et al. (2004): The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172: 3157-3166.
34. Taylor JJ, Mohrs M, Pearce EJ (2006): Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol 176: 5839-5847.
35. Wacker A, Eilmes HG (1975): Virus inhibition using hesperidin. Naturwissenschaften 62: 301.
36. Galati EM, Monforte MT, Kirjavainen S, et al. (1994): Biological effects of hesperidin, a citrus flavonoid (Note I): antiinflammatory and analgesic activity. Farmacol 40: 709-712.
37. Patil JR, Murthy KNC, Jayaprakasha GK, et al. (2009): Bioactive compounds from Mexican lime (Citrus aurantifolia) juice induce apoptosis in human pancreatic cells. J Agric Food Chem 57: 10933-10942.
38. Pałgan K, Bartuzi Z (2011): The role of flavonoids in asthma. Post Dermatol Alergol 28: 396-401.
39. Zielinska-Przyjemska M, Ignatowicz E (2008): Citrus fruit flavonoids influence on neutrophil apoptosis and oxidative metabolism. Phytother Res 22: 1557-1562.
40. Park HJ, Kim MJ, Ha E, et al. (2008): Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4. Phytomedicine 15: 147-151.
41. Vinson JA, Liang X, Proch J, et al. (2002): Polyphenol antioxidants in citrus juices: in vitro and in vivo studies relevant to heart disease. Adv Exp Med Biol 505: 113-122.
42. Wilmsen PK, Spada DS, Salvador M (2005): Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem 53: 4757-4761.
43. Sakata K, Hirose Y, Qiao Z, et al. (2003): Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line. Cancer Lett 199: 139-145.
44. Choi YJ, Kang JS, Park JH, et al. (2003): Polyphenolic flavonoids differ in their antiapoptotic efficacy in hydrogen peroxide-treated human vascular endothelial cells. J Nutr 133: 985-991.
45. Kang SR, Han DY, Park KI, et al. (2011): Suppressive effect on lipopolysaccharide-induced proinflammatory mediators by Citrus aurantium L. in macrophage RAW 264.7 cells via NF-κB signal pathway. Evid Based Complement Alternat Med 2011 pii: 248592.
46. Kang SR, Park K, Park HS, et al. (2011): Anti-inflammatory effect of flavonoids isolated from Korea Citrus aurantium L. on lipopolysaccharide-induced mouse macrophage RAW264.7 cells by blocking of nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signalling pathways. Food Chem 129: 1721-1728.
47. Kawaguchi K, Kikuchi S, Hasunuma R, et al. (2004): Acitrus flavonoid hesperidin suppresses infection induced endotoxin shock in mice. Biol Pharm Bull 27: 679-683.
48. Yeh CC, Kao SJ, Lin CC, et al. (2007): The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci 80: 1821-1831.
49. Choi IY, Kim SJ, Jeong HJ, et al. (2007): Hesperidin inhibits expression of hypoxia inducible factor-1 alpha and inflammatory cytokine production from mast cells. Mol Cell Biochem 305: 153-161.
50. Xu L, Yang ZL, Li P, et al. (2009): Modulating effect of hesperidin on experimental murine colitis induced by dextran sulfate sodium. Phytomedicine 16: 989-995.
51. Lee YR, Jung JH, Kim HS (2011): Hesperidin partially restores impaired immune and nutritional function in irradiated mice. J Med Food 14: 475-482.
52. Raza SS, Khan MM, Ahmad A, et al. (2011): Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke. Brain Res 1420: 93-105.
53. Kim SH, Kim BK, Lee YC (2011): Antiasthmatic effects of hesperidin, a potential Th2 cytokine antagonist, in a mouse model of allergic asthma. Mediators Inflamm 2011: 485402.
54. Ok IS, Kim SH, Kim BK, et al. (2009): Pinellia ternata, Citrus reticulata, and their combinational prescription inhibit eosinophil infiltration and airway hyper-responsiveness by suppressing CCR3+ and Th2 cytokines production in the ovalbumin-induced asthma model.Mediators Inflamm 2009: 413270.
55. Tanabe S, Kinuta Y, Yasumatsu H, et al. (2007): Effects of Citrus unshiupowder on the cytokine balance in peripheral blood mononuclear cells of patients with seasonal allergic rhinitis to pollen. Biosci Biotechnol Biochem 7: 2852-2855.
56. Schubert M(1948): Conditions for drug testing in experimental Schistosomiasis mansoni in mice. Am J Trop Med 28: 121-136.
57. Bruce JI, Radke MG (1971): Culturing Biomphalaria and Oncomelania (Gastropoda) for large-scale studies of schistosomiasis. I. Cultivation of Biomphalaria glabrata and maintenance of Schistosoma mansoni in the laboratory. Biomed Rep 406th Med Lab 19: 1-84.
58. Lowry OH, Rosenbrough NJ, Farr AL, et al. (1951): Protein measurement with Folin-Phenol reagent. J Biol Chem 193: 265-275.
59. Fallon PG, Smith P, Dunne DW (1998): Type 1 and type 2 cytokine producing mouse CD4+ and CD8+ T cells in acute Schistosoma mansoni infection. Eur J Immunol 28: 1408-1416.
60. Cheever AW, Yap GS (1997): Immunologic basis of disease and disease regulation in schistosomiasis. Chem Immunol 66: 159-176.
61. Brunet LR, Finkelman FD, Cheever AW, et al. (1997): IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J Immunol 159: 777-785.
62. Moore KW, O'Garra A, Malefyt RW, et al. (1993): Interleukin-10.Annu Rev Immunol 11: 165-190.
63. Hoffmann KF, Cheever AW, Wynn TA (2000): IL-10 and the dangers of immune polarization, excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164: 6406-6416.
64. LaFlamme AC, Patton EA, Bauman B, et al. (2001): IL-4 plays a crucial role in regulating oxidative damage in liver during Schistosomiasis. J Immunol 166: 1903-1911.
65. Brunet LR, Dunne DW, Pearce EJ (1998): Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitol Today 14: 422-427.
66. Chiaramonte MG, Cheever AW, Malley JD, et al. (2001): Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatol 34: 273-282.
67. de Jesus AR, Magalhães A, Miranda DG, et al. (2004): Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun 72: 3391-3397.
68. Chiaramonte MG, Donaldson DD, Cheever AW, et al. (1999): An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104: 777-785.
69. Kaviratne M, Hesse M, Leusink M, et al. (2004): IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol 173: 4020-4029.
70. Nworu CS, Akah PA, Okoye FB, et al. (2012): Supplementation with aqueous leaf extract of Morinda lucida enhances immunorestoration and upregulates the expression of cytokines and immunostimulatory markers. Immunol Invest 41: 799-819.
71. Wynn TA, Oswald IP, Eltoum IA, et al. (1994): Elevated expression of Th1 cytokines and nitric oxide synthase in the lung of vaccinated mice after challenge infection with Schistosomiasis mansoni. J Immunol 153: 5200-5209.
72. Oswald IP, Eltoum I, Wynn TA, et al. (1994): Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production nitric oxide. Proc Natl Acad Sci U S A91: 999-1003.
73. Doenhoff MJ (1997): Arole for granulomatous inflammation in the transmission of infectious disease: schistosomiasis and tuberculosis. Parasitol 115: 113-125.
74. Silva L, Fernandes A, Barbosa A, et al. (2000): Significance of Schistosomal granuloma modulation. Mem Inst Oswaldo Cruz 95: 353-361.
75. Czaja MJ, Weiner FR, Takahashi S, et al. (1989): Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatol 10: 795-800.
76. Dinarello CA(1994): The biological properties of interleukin-1. Eur Cytokine Netw 5: 517-531.
77. Krakauer T, Vilcek J, Oppenheim JJ (1999): Proinflammatory cytokines TNF and IL-1 families, chemokines, TGF-β, and others. In: Fundamental immunology. Paul WE (ed.). Lippincott-Raven, Philadelphia, 775-811.
78. El Ridi R, Wagih A, Salem R, et al. (2006): Impact of interleukin-1 and interleukin-6 in murine primary schistosomiasis. Int Immunopharmacol 6: 1100-1108.
79. Abbas AK, Murphy KM, Sher A (1996): Functional diversity of helper T lymphocytes. Nature 383: 787-793.
80. Wynn TA, Reynolds A, James S, et al. (1996): IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol 157: 4068-4078.
81. Amiri P, Locksley RM, Parslow TG, et al. (1992): Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 356: 604-607.
82. Gharib B, Abdallahi OM, Dessein H, et al. (1999): Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defenses in the liver of mice infected with Schistosoma mansoni. J Hepatol 30: 594-602.
83. Allam G (2009): Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Immunobiol 214: 712-727.